GEVORKYAN, a.s.
17.2.2026 08:00:00 CET | Globenewswire | Press release
GEVORKYAN in the Portfolio of a Goldman Sachs Fund
GEVORKYAN in the Portfolio of a Goldman Sachs Fund
„According to publicly available data, the Goldman Sachs Central Europe Equity fund, managed by Goldman Sachs, holds an exposure to GEVORKYAN, a.s. within its regional investment strategy focused on Central Europe, with this position having been recorded in the fund’s portfolio for more than three years. Although the position represents a relatively small weight in the context of the overall portfolio, the long-term presence of a global asset manager in the shareholder structure of the Slovak company is a relevant fact from the perspective of its international investment visibility,“ states analyst Miroslav Gáfrik of Gafrik Research.
GEVORKYAN Share Analysis: Target Price +26%
“We initiate coverage with a BUY recommendation and a target price of EUR 12.34, implying an upside potential of +26% compared to the current market price,” states Gafrik Research.
GEVORKYAN, a.s. informs about the update of analytical coverage of its shares by the independent platform Gafrik Research. The full version of the published report is available here: https://www.gafrikresearch.sk/gevorkyan-a-s-quarterly-update-initiation-report-9m-2025/
“GEVORKYAN, a.s. is in the final phase of an investment cycle in the amount of EUR 60–80 million (2023–2026), focused on automation, capacity expansion and higher value-added applications. For 9M 2025, the company achieved revenues of EUR 63.5 million (+8.7% y/y) and EBITDA of EUR 23.0 million (+17.2% y/y), while the EBITDA margin reached 36.2%, the highest level within the peer group. Long-term contracts ensure more than 90% revenue visibility, supporting earnings stability during the investment phase,” writes Gafrik Research.
Source: Gafrik Research – Initiation Quarter Report 9M 2025
About GEVORKYAN, a.s.
GEVORKYAN, a.s. is a leading European company in powder metallurgy, a global supplier to major multinational corporations and one of the most innovative companies in the sector worldwide. More information is available at https://www.gevorkyan.eu/en.
About Gafrik Research
Gafrik Research is an independent research and analytical platform focused on the Czech and Slovak markets. It provides detailed information on companies, markets and strategic sectors and delivers clear, data-driven analyses that support investment and business decision-making.
Contact Information
Media: Alexandra Hazuchová, marketing@gevorkyan.sk
Financial matters: Andrej Bátovský, andrej.batovsky@gevorkyan.sk
Disclaimer
This information relates to an independent equity research report prepared by Gafrik Research. The target price and opinions contained in the report represent the independent views of Gafrik Research and do not constitute investment advice or a recommendation by GEVORKYAN, a.s. The company bears no responsibility for the content of the analytical report.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanofi Winthrop Industrie17.2.2026 12:00:00 CET | Press release
Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Teva Pharmaceutical Industries Ltd17.2.2026 12:00:00 CET | Press release
Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Nykredit Realkredit A/S17.2.2026 10:31:17 CET | Press release
New final terms for Euro Medium Term Note Programme - Nykredit Realkredit A/S
Sveriges Riksbank17.2.2026 10:15:00 CET | Press release
RESULT OF RIKSBANK CERTIFICATE SALE
Normative AB17.2.2026 10:00:00 CET | Press release
Normative Launches Carbon Inventory Managed Services to Eliminate the Biggest Bottleneck in Carbon Accounting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom